Digital Patient Education Platform in Head and Neck Cancer

Head and Neck Cancer Clinical Trial

Official title:

Post-Operative Patient-Centred Care Education Administration in Head and Neck Cancer Patients - A Digital Platform

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05211778
• Other study ID #: H16-01039
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 8, 2019
• Est. completion date: June 1, 2022

Study information

• Verified date: January 2022
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Head and neck cancer is a disease that has a particular propensity for treatment-related morbidity. It is hypothesized that patients who are more involved in their care in hospital and who are actively provided with more treatment-related education may report increased satisfaction and have improved overall outcomes. The investigators aim to determine whether delivery of patient-centred education in a multimedia format via a digital platform has an impact on overall satisfaction and perceived quality of medical care.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 35
• Est. completion date: June 1, 2022
• Est. primary completion date: March 26, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Patients aged 19 years old or above
• Patients seen in outpatient clinic who are scheduled to undergo reconstructive head and neck surgeries for a confirmed oral or oropharyngeal cancer diagnosis.

Exclusion Criteria:

• Patients who are unable to use a digital tablet
• Patients who do not speak or read English
• Individuals unable to understand the purpose, methods and conduct of this study
• Patients unwilling to provide informed consent

Related Conditions & MeSH terms

• Head and Neck Cancer
• Head and Neck Neoplasms

Intervention

Behavioral:
• Digital Education Group
Multimedia education provided to the intervention group via a digital tablet

Locations

Country	Name	City	State
Canada	Vancouver General Hospital	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Satisfaction	Measured via a 5-point Likert scale from a survey collected on discharge day	From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.
Secondary	Perceived quality of medical care	Measured via a 5-point Likert scale from a survey collected on discharge day	From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.